Company Filing History:
Years Active: 2017-2018
Title: The Innovative Contributions of Daniel Hillesheim
Introduction
Daniel Hillesheim is a notable inventor based in Knoxville, TN (US). He has made significant contributions to the field of biomarker production and radiopharmaceuticals. With a total of 2 patents, his work focuses on enhancing the efficiency and effectiveness of medical imaging technologies.
Latest Patents
Hillesheim's latest patents include a "Dose synthesis card for use with automated biomarker production system" and a "Microfluidic radiopharmaceutical production system and process for synthesizing per run approximately, but not less than, ten (10) unit doses of radiopharmaceutical biomarker for use in positron emission tomography (PET)." These innovations involve introducing a radioisotope into a reaction vessel with organic and aqueous reagents, which are then heated to synthesize a solution of a pre-selected radiopharmaceutical. The purification process reduces waste and allows for on-site production of biomarker radiopharmaceuticals, minimizing the time between synthesis and administration to patients.
Another significant patent is for "Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same." This coating exhibits an average contact angle of at least 100 degrees with a drop of water and can be produced using low-cost, environmentally friendly components. The methods of preparing and using this coating have broad applications in various industries.
Career Highlights
Throughout his career, Hillesheim has worked with reputable organizations such as UT-Battelle, Inc. and Abt Molecular Imaging, Inc. His experience in these companies has allowed him to develop and refine his innovative ideas in the field of radiopharmaceuticals and biomarker production.
Collaborations
Hillesheim has collaborated with talented individuals, including Beth Louise Armstrong and Tolga Aytug. These partnerships have contributed to the advancement of his projects and the successful development of his patents.
Conclusion
Daniel Hillesheim's contributions to the field of radiopharmaceuticals and biomarker production demonstrate his commitment to innovation and improving medical technologies. His patents reflect a deep understanding of the challenges in the industry and offer practical solutions that enhance patient care.